Suzuki et al. [25] showed a beneficial effect of treatment ACEi to restore the activity of cathepsin B in the heart and Kim et al. [26] demonstrated that combination therapy ACEi and ARB (angiotensin-II receptor blocker) can effectively prevent or reverse myocardial fibrosis. Here, CTSB is linked to Myocardial fibrosis.